GRAY SUSANNAH

Director at ANAPTYSBIO, INC · on record since Apr 3, 2026
Director at MARAVAI LIFESCIENCES HOLDINGS, INC. · on record since May 28, 2026
Director at Theravance Biopharma, Inc. · on record since Jun 16, 2026
Director at Apria, Inc. · on record since Jun 14, 2021
Director at 4D Molecular Therapeutics, Inc. · on record since Dec 10, 2020
Director at Morphic Holding, Inc. · on record since Apr 29, 2021

Insider trading activity of GRAY SUSANNAH

Transactions on record: 38; since Nov 23, 2020

Open-market buys: 1; $540K

Open-market sells: 0

Companies traded: 6; last filing Jun 18, 2026

Figures computed from official regulatory filings — methodology.

Companies where GRAY SUSANNAH has traded

4D Molecular Therapeutics, Inc.6 tx · Jun 18, 2026
Theravance Biopharma, Inc.12 tx · Jun 16, 2026
MARAVAI LIFESCIENCES HOLDINGS, INC.7 tx · $955.1K · May 28, 2026
ANAPTYSBIO, INC1 tx · Apr 29, 2026
Morphic Holding, Inc.10 tx · Aug 20, 2024
Apria, Inc.2 tx · $189.7K · Mar 29, 2022

Track record of GRAY SUSANNAH

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of GRAY SUSANNAH

Co-insiders of GRAY SUSANNAH

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
4D Molecular Therapeutics, Inc.	Jun 18, 2026	AwardD	50,000	0.00 USD	—	SEC
Theravance Biopharma, Inc.	Jun 16, 2026	Award	6,009	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	Jun 16, 2026	AwardD	13,398	0.00 USD	$0	SEC
MARAVAI LIFESCIENCES HOLDINGS, INC.	May 28, 2026	Award	46,293	0.00 USD	$0	SEC
ANAPTYSBIO, INC	Apr 29, 2026	AwardD	11,250	0.00 USD	$0	SEC
4D Molecular Therapeutics, Inc.	Jun 20, 2025	AwardD	22,500	0.00 USD	$0	SEC
MARAVAI LIFESCIENCES HOLDINGS, INC.	Jun 18, 2025	Award	89,139	2.16 USD	$192.5K	SEC
Theravance Biopharma, Inc.	May 21, 2025	AwardD	24,258	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 21, 2025	Award	10,649	0.00 USD	$0	SEC
Morphic Holding, Inc.	Aug 20, 2024	OtherD	-12,535	—	—	SEC
Morphic Holding, Inc.	Aug 20, 2024	OtherD	-17,550	—	—	SEC
Morphic Holding, Inc.	Aug 20, 2024	OtherD	-18,111	—	—	SEC
Morphic Holding, Inc.	Aug 20, 2024	OtherD	-23,168	—	—	SEC
Morphic Holding, Inc.	Jun 5, 2024	AwardD	23,168	0.00 USD	$0	SEC
MARAVAI LIFESCIENCES HOLDINGS, INC.	May 24, 2024	Award	20,645	10.78 USD	$222.6K	SEC
4D Molecular Therapeutics, Inc.	May 23, 2024	AwardD	22,500	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 10, 2024	Award	10,537	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 10, 2024	AwardD	23,576	0.00 USD	$0	SEC
MARAVAI LIFESCIENCES HOLDINGS, INC.	Jul 19, 2023	Award	24,000	0.00 USD	$0	SEC
Morphic Holding, Inc.	Jun 2, 2023	AwardD	12,535	0.00 USD	$0	SEC
4D Molecular Therapeutics, Inc.	May 25, 2023	AwardD	22,500	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 4, 2023	Award	9,132	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 4, 2023	AwardD	22,044	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	Feb 28, 2023	AwardD	4,666	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	Feb 28, 2023	AwardD	28,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
4D Molecular Therapeutics, Inc.	Jun 18, 2026	AwardD	50,000	0.00 USD	—	SEC
Theravance Biopharma, Inc.	Jun 16, 2026	Award	6,009	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	Jun 16, 2026	AwardD	13,398	0.00 USD	$0	SEC
MARAVAI LIFESCIENCES HOLDINGS, INC.	May 28, 2026	Award	46,293	0.00 USD	$0	SEC
ANAPTYSBIO, INC	Apr 29, 2026	AwardD	11,250	0.00 USD	$0	SEC
4D Molecular Therapeutics, Inc.	Jun 20, 2025	AwardD	22,500	0.00 USD	$0	SEC
MARAVAI LIFESCIENCES HOLDINGS, INC.	Jun 18, 2025	Award	89,139	2.16 USD	$192.5K	SEC
Theravance Biopharma, Inc.	May 21, 2025	AwardD	24,258	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 21, 2025	Award	10,649	0.00 USD	$0	SEC
Morphic Holding, Inc.	Aug 20, 2024	OtherD	-12,535	—	—	SEC
Morphic Holding, Inc.	Aug 20, 2024	OtherD	-17,550	—	—	SEC
Morphic Holding, Inc.	Aug 20, 2024	OtherD	-18,111	—	—	SEC
Morphic Holding, Inc.	Aug 20, 2024	OtherD	-23,168	—	—	SEC
Morphic Holding, Inc.	Jun 5, 2024	AwardD	23,168	0.00 USD	$0	SEC
MARAVAI LIFESCIENCES HOLDINGS, INC.	May 24, 2024	Award	20,645	10.78 USD	$222.6K	SEC
4D Molecular Therapeutics, Inc.	May 23, 2024	AwardD	22,500	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 10, 2024	Award	10,537	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 10, 2024	AwardD	23,576	0.00 USD	$0	SEC
MARAVAI LIFESCIENCES HOLDINGS, INC.	Jul 19, 2023	Award	24,000	0.00 USD	$0	SEC
Morphic Holding, Inc.	Jun 2, 2023	AwardD	12,535	0.00 USD	$0	SEC
4D Molecular Therapeutics, Inc.	May 25, 2023	AwardD	22,500	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 4, 2023	Award	9,132	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	May 4, 2023	AwardD	22,044	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	Feb 28, 2023	AwardD	4,666	0.00 USD	$0	SEC
Theravance Biopharma, Inc.	Feb 28, 2023	AwardD	28,000	0.00 USD	$0	SEC